PL2564397T3 - Sposób wytwarzania izotopów - Google Patents

Sposób wytwarzania izotopów

Info

Publication number
PL2564397T3
PL2564397T3 PL11719187T PL11719187T PL2564397T3 PL 2564397 T3 PL2564397 T3 PL 2564397T3 PL 11719187 T PL11719187 T PL 11719187T PL 11719187 T PL11719187 T PL 11719187T PL 2564397 T3 PL2564397 T3 PL 2564397T3
Authority
PL
Poland
Prior art keywords
production method
isotope production
isotope
production
Prior art date
Application number
PL11719187T
Other languages
English (en)
Inventor
Jan Roger Karlson
Peer Børretzen
Original Assignee
Algeta Asa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Algeta Asa filed Critical Algeta Asa
Publication of PL2564397T3 publication Critical patent/PL2564397T3/pl

Links

Classifications

    • G—PHYSICS
    • G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
    • G21G1/00—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/12—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by a special physical form, e.g. emulsion, microcapsules, liposomes, characterized by a special physical form, e.g. emulsions, dispersions, microcapsules
    • A61K51/1282—Devices used in vivo and carrying the radioactive therapeutic or diagnostic agent, therapeutic or in vivo diagnostic kits, stents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
    • G21G1/00—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
    • G21G1/0005—Isotope delivery systems
    • G—PHYSICS
    • G21—NUCLEAR PHYSICS; NUCLEAR ENGINEERING
    • G21G—CONVERSION OF CHEMICAL ELEMENTS; RADIOACTIVE SOURCES
    • G21G1/00—Arrangements for converting chemical elements by electromagnetic radiation, corpuscular radiation or particle bombardment, e.g. producing radioactive isotopes
    • G21G1/001—Recovery of specific isotopes from irradiated targets
    • G21G2001/0042—Technetium

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • High Energy & Nuclear Physics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Radiation-Therapy Devices (AREA)
  • Manufacture And Refinement Of Metals (AREA)
  • Medicinal Preparation (AREA)
PL11719187T 2010-04-30 2011-04-29 Sposób wytwarzania izotopów PL2564397T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB1007353.4A GB201007353D0 (en) 2010-04-30 2010-04-30 Method
EP11719187.4A EP2564397B1 (en) 2010-04-30 2011-04-29 Isotope production method
PCT/EP2011/002156 WO2011134672A1 (en) 2010-04-30 2011-04-29 Isotope production method

Publications (1)

Publication Number Publication Date
PL2564397T3 true PL2564397T3 (pl) 2014-10-31

Family

ID=42289983

Family Applications (1)

Application Number Title Priority Date Filing Date
PL11719187T PL2564397T3 (pl) 2010-04-30 2011-04-29 Sposób wytwarzania izotopów

Country Status (20)

Country Link
US (1) US9056142B2 (pl)
EP (2) EP2733705A1 (pl)
JP (1) JP5969462B2 (pl)
KR (1) KR101886883B1 (pl)
CN (1) CN102985980B (pl)
AU (1) AU2011247362B2 (pl)
BR (1) BR112012027945B1 (pl)
CA (1) CA2797901C (pl)
CY (1) CY1115352T1 (pl)
DK (1) DK2564397T3 (pl)
EA (1) EA022226B1 (pl)
ES (1) ES2473266T3 (pl)
GB (1) GB201007353D0 (pl)
IL (1) IL222764A (pl)
MX (1) MX2012012669A (pl)
NZ (1) NZ603460A (pl)
PL (1) PL2564397T3 (pl)
PT (1) PT2564397E (pl)
SG (1) SG185106A1 (pl)
WO (1) WO2011134672A1 (pl)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201002508D0 (en) 2010-02-12 2010-03-31 Algeta As Product
US20150343099A1 (en) 2012-12-19 2015-12-03 Bayer Pharma Aktiengesellschaft Combination comprising radium-223 for the treatment of cancer
GB201314718D0 (en) * 2013-08-16 2013-10-02 Algeta As Quantification method
CN105934256B (zh) 2013-12-03 2019-12-27 拜耳制药股份公司 Pi3k-抑制剂的组合产品
WO2015082378A1 (en) 2013-12-03 2015-06-11 Bayer Pharma Aktiengesellschaft Combination of pi3k-inhibitors
WO2015137451A1 (ja) * 2014-03-13 2015-09-17 株式会社クラレ 重合体、吸着材、並びにその製造方法
WO2015173098A1 (en) * 2014-05-13 2015-11-19 Paul Scherrer Institut Production of 43sc radionuclide and radiopharmaceuticals thereof for use in positron emission tomography
WO2016083739A1 (fr) 2014-11-26 2016-06-02 Rhodia Operations Composition de lanthane et d'actinium-227
GB201600153D0 (en) * 2016-01-05 2016-02-17 Bayer As Isotope preparation method
CZ306722B6 (cs) * 2016-03-16 2017-05-24 ÄŚeskĂ© vysokĂ© uÄŤenĂ­ technickĂ© v Praze Způsob izolace Ac ze směsi radia, aktinia a thoria
WO2018035020A1 (en) * 2016-08-16 2018-02-22 Mallinckrodt Nuclear Medicine Llc Chromatographic separation of mo-99 from w-187
US10344355B2 (en) * 2016-08-22 2019-07-09 Uchicago Argonne, Llc Process for the separation and purification of scandium medical isotopes
US10704123B2 (en) 2016-08-22 2020-07-07 Uchicago Argonne, Llc Process for the separation and purification of medical isotopes
WO2018153969A1 (en) 2017-02-24 2018-08-30 Bayer Aktiengesellschaft Combination of atr kinase inhibitors with radium-223 salt
EP3980163A4 (en) * 2019-06-05 2023-05-10 Battelle Memorial Institute SYSTEMS AND PROCESSES FOR SEPARATION OF RADIUM FROM LEAD, BISMUTH AND THORIUM
RU2752845C1 (ru) * 2020-05-13 2021-08-11 Акционерное Общество "Наука И Инновации" Способ получения высокочистого радия-223
CN114873626B (zh) * 2021-12-31 2023-09-19 中国工程物理研究院核物理与化学研究所 一种176Yb2O3和160Gd2O3靶料回收方法
CN115869658B (zh) * 2022-12-29 2025-01-28 中国核动力研究设计院 用于制备Ra-223的分离系统及其分离方法、应用和制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4390517A (en) 1979-12-19 1983-06-28 New England Nuclear Corporation Method, composition and kit for stabilizing radiolabeled compounds
US5809394A (en) 1996-12-13 1998-09-15 Battelle Memorial Institute Methods of separating short half-life radionuclides from a mixture of radionuclides
JP3832961B2 (ja) * 1998-03-10 2006-10-11 ユニチカ株式会社 ラジウム吸着剤の再生方法
NO310544B1 (no) 1999-01-04 2001-07-23 Algeta As Opparbeidelse og anvendelse av radium-223 til fremstilling av preparat samt kit til behandling av kalsifisert vev for palliasjon, benkreft-terapi og/eller overflatebehandling av ben
JP4380875B2 (ja) * 2000-02-29 2009-12-09 株式会社東芝 液体処理装置
JP2001318087A (ja) * 2000-05-11 2001-11-16 Kawasaki Steel Corp 液体クロマトグラフィー用カラム及びその使用方法
CN1258385C (zh) * 2001-06-22 2006-06-07 Pg研究基金会公司 放射性核素自动化分离系统和方法
EA007452B1 (ru) * 2002-04-12 2006-10-27 Пи Джи Рисерч Фаундейшн, Инк. Многоколоночный генератор с инверсией избирательности для производства сверхчистых радионуклидов
US7157022B2 (en) 2002-09-30 2007-01-02 .Pg Research Foundation, Inc. Multivalent metal ion extraction using diglycolamide-coated particles
US7087206B2 (en) * 2002-04-12 2006-08-08 Pg Research Foundation Multicolumn selectivity inversion generator for production of high purity actinium for use in therapeutic nuclear medicine
US20070009409A1 (en) 2005-07-11 2007-01-11 Hariprasad Gali 212Bi or 213Bi Generator from supported parent isotope
EP2796575B8 (en) * 2006-09-08 2020-04-01 Actinium Pharmaceuticals, Inc. Method for the purification of radium from different sources
GB201007354D0 (en) * 2010-04-30 2010-06-16 Algeta Asa Method

Also Published As

Publication number Publication date
US9056142B2 (en) 2015-06-16
DK2564397T3 (da) 2014-06-23
EA201291061A1 (ru) 2013-05-30
EP2564397A1 (en) 2013-03-06
NZ603460A (en) 2014-09-26
BR112012027945B1 (pt) 2022-07-26
JP2013533459A (ja) 2013-08-22
CN102985980A (zh) 2013-03-20
PT2564397E (pt) 2014-06-25
ES2473266T3 (es) 2014-07-04
AU2011247362B2 (en) 2014-11-27
US20130095031A1 (en) 2013-04-18
IL222764A0 (en) 2012-12-31
KR20130111930A (ko) 2013-10-11
BR112012027945A2 (pl) 2017-08-15
HK1183557A1 (en) 2013-12-27
EP2564397B1 (en) 2014-03-19
CN102985980B (zh) 2015-08-12
EA022226B1 (ru) 2015-11-30
GB201007353D0 (en) 2010-06-16
MX2012012669A (es) 2013-03-08
CA2797901A1 (en) 2011-11-03
WO2011134672A1 (en) 2011-11-03
SG185106A1 (en) 2012-12-28
KR101886883B1 (ko) 2018-08-08
JP5969462B2 (ja) 2016-08-17
CY1115352T1 (el) 2017-01-04
CA2797901C (en) 2019-02-26
IL222764A (en) 2016-07-31
EP2733705A1 (en) 2014-05-21

Similar Documents

Publication Publication Date Title
IL222764A0 (en) Isotope production method
ZA201300297B (en) Isotope production target
GB201001833D0 (en) Method
PL2760619T3 (pl) Sposób wytwarzania struktury
IL222763A0 (en) Isotope preparation method
GB201004759D0 (en) Method
PL2739412T3 (pl) Wytwarzanie puszek
GB201011513D0 (en) Method
HU1000330D0 (en) Novel method
IL223583A (en) A method for the production of quinoline-3-carboxamides
GB201006306D0 (en) Method
EP2653482A4 (en) PROCESS FOR PRODUCING PSEUDOPOLYROTAXANE
GB201012148D0 (en) Method
GB201012784D0 (en) Method
GB201010855D0 (en) Method
GB201007207D0 (en) Method
GB201017003D0 (en) Method
GB201007522D0 (en) Method
GB201017043D0 (en) Component production method
GB201009259D0 (en) Production process
GB201013203D0 (en) New process
GB201015343D0 (en) New process
GB201021522D0 (en) Novel compounds and methods for their production
GB201121535D0 (en) Manufacturing method
GB201004760D0 (en) Method